JOURNAL,O
OF,O
ADVANCED,O
VETERINARY,O
AND,O
ANIMAL,O
RESEARCH,O
A,O
periodical,O
of,O
the,O
Network,O
for,O
the,O
Veterinarians,MISC
of,O
Bangladesh,COUNTRY
(,O
BDvetNET,O
),O
VOL,O
7,NUMBER
.,O
NO,O
.,O
2,NUMBER
.,O
PAGES,O
198208,NUMBER
REVIEW,O
ARTICLE,O
The,O
emergence,O
of,O
novel,O
coronavirus,O
disease,CAUSE_OF_DEATH
(,O
COVID,O
‐,O
19,NUMBER
),O
in,O
Bangladesh,COUNTRY
:,O
Present,DATE
status,O
.,O
challenges,O
.,O
and,O
future,DATE
management,O
Mohammad,PERSON
Shah,PERSON
Alam1,O
.,O
Mohammad,PERSON
Zahangeer,O
Alam2,O
.,O
K.,PERSON
H.,PERSON
M.,PERSON
Nazmul,PERSON
Hussain,PERSON
Nazir3,O
.,O
Md,STATE_OR_PROVINCE
.,O
Abdullahil,PERSON
Baki,PERSON
Bhuiyan4,O
ARTICLE,O
HISTORY,O
Immediate,O
after,O
the,O
official,O
decla,O
‐,O
ration,O
of,O
COVID,O
‐,O
19,NUMBER
in,O
Bangladesh,COUNTRY
on,O
8,DATE
March,DATE
2020,DATE
.,O
it,O
has,O
created,O
public,O
panic,O
which,O
results,O
in,O
price,O
plummeting,O
of,O
the,O
capital,O
market,O
and,O
price,O
hike,O
of,O
many,O
essential,O
commodities,O
.,O
Worldwide,O
.,O
the,O
outbreak,O
of,O
COVID,O
‐,O
19,NUMBER
has,O
declared,O
a,O
pandemic,O
.,O
In,O
response,O
.,O
the,O
Government,O
of,O
Bangladesh,COUNTRY
has,O
initiated,O
some,O
strict,O
measures,O
such,O
as,O
stopping,O
the,O
entry,O
of,O
passengers,O
from,O
Europe,LOCATION
.,O
stopping,O
on,O
‐,O
arrival,O
visas,O
and,O
self,O
‐,O
quarantine,O
for,O
2,DURATION
weeks,DURATION
for,O
all,O
passen,O
‐,O
gers,O
return,O
from,O
abroad,O
.,O
Still,O
.,O
many,O
loopholes,O
exist,O
at,O
the,O
entry,O
points,O
of,O
Bangladesh,COUNTRY
.,O
Most,O
of,O
the,O
people,O
of,O
Bangladesh,COUNTRY
are,O
yet,O
to,O
aware,O
of,O
the,O
consequences,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
In,O
this,O
backdrop,O
.,O
this,O
would,O
be,O
helpful,O
to,O
undertake,O
future,DATE
management,O
practices,O
against,O
the,O
fearsome,O
COVID,O
‐,O
19,NUMBER
in,O
Revised,O
March,DATE
17,DATE
.,DATE
2020,DATE
The,O
coronavirus,O
was,O
first,ORDINAL
isolated,O
in,O
1937,DATE
.,O
which,O
caused,O
bronchitis,CAUSE_OF_DEATH
in,O
birds,O
[,O
1.2,NUMBER
],O
.,O
However,O
.,O
human,O
coronaviruses,O
(,O
HCoV,O
‐,O
229E,O
and,O
HCoV,O
‐,O
OC43,O
),O
were,O
first,ORDINAL
characterized,O
in,O
the,DATE
1960s,DATE
[,O
3,NUMBER
],O
.,O
which,O
were,O
associated,O
with,O
diseases,CAUSE_OF_DEATH
in,O
respiratory,O
tracts,O
such,O
as,O
bronchitis,CAUSE_OF_DEATH
and,O
pneu,O
‐,O
monia,O
and,O
illnesses,O
in,O
the,O
enteric,O
and,O
central,O
nervous,O
system,O
[,O
3.4,NUMBER
],O
.,O
The,O
virus,O
is,O
named,O
as,O
coronavirus,O
for,O
the,O
crown,O
‐,O
like,O
spikes,O
on,O
their,O
surface,O
[,O
5,NUMBER
],O
.,O
According,O
to,O
the,O
Centers,O
for,O
Disease,CAUSE_OF_DEATH
Control,ORGANIZATION
and,ORGANIZATION
Prevention,ORGANIZATION
.,O
Atlanta,CITY
.,O
USA,COUNTRY
.,O
the,O
syndrome,O
of,O
coronavirus,O
is,O
called,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
.,O
The,O
virus,O
SARS,O
‐,O
associated,O
coronavirus,O
(,O
SARS,O
‐,O
CoV,O
),O
has,O
received,O
worldwide,O
at,O
‐,O
tention,O
due,O
to,O
its,O
epidemic,O
appearance,O
in,O
2003,DATE
.,O
Since,O
then,O
.,O
a,O
to,O
‐,O
tal,O
of,O
8.098,NUMBER
people,O
became,O
sick,O
.,O
which,O
claimed,O
774,NUMBER
lives,O
across,O
the,O
globe,O
[,O
6,NUMBER
],O
.,O
However,O
.,O
there,O
were,O
no,O
known,O
cases,O
of,O
SARS,O
report,O
‐,O
ed,O
anywhere,O
in,O
the,O
world,O
Correspondence,O
Md,STATE_OR_PROVINCE
.,O
Abdullahil,PERSON
Baki,PERSON
Bhuiyan,O
Coronavirus,O
;,O
outbreak,O
;,O
fatality,O
;,O
pneumonia,CAUSE_OF_DEATH
;,O
Bangladesh,COUNTRY
distributed,O
under,O
the,O
terms,O
of,O
the,O
after,O
2004,DATE
[,O
7,NUMBER
],O
.,O
Recently,DATE
.,O
a,O
novel,O
coronavirus,O
named,O
SARSCoV,O
‐,O
2,NUMBER
has,O
spread,O
worldwide,O
[,O
8,NUMBER
],O
.,O
in,O
‐,O
cluding,O
Bangladesh,COUNTRY
.,O
which,O
is,O
one,NUMBER
of,O
the,O
most,O
densely,O
populated,O
countries,O
(,O
160,NUMBER
million,NUMBER
),O
in,O
the,O
world,O
[,O
9,NUMBER
],O
.,O
Although,O
overpopulated,O
.,O
the,O
economy,O
of,O
Bangladesh,COUNTRY
is,O
booming,O
in,O
recent,O
times,O
[,O
8,NUMBER
],O
.,O
Since,O
its,O
independence,O
in,O
1971,DATE
.,O
the,O
annual,SET
gross,O
domestic,O
product,O
in,O
Bangladesh,COUNTRY
was,O
8.75,MONEY
billion,MONEY
.,O
which,O
is,O
expected,O
to,O
reach,O
315.00,NUMBER
billion,NUMBER
USD,O
by,O
the,DATE
end,DATE
of,DATE
2020,DATE
[,O
8,NUMBER
],O
.,O
In,O
this,O
situation,O
.,O
the,O
emer,O
‐,O
gence,O
of,O
novel,O
coronavirus,O
(,O
COVID,O
‐,O
19,NUMBER
),O
in,O
Bangladesh,COUNTRY
could,O
be,O
a,O
threat,O
to,O
the,O
boosting,O
economy,O
.,O
Taxonomy,O
.,O
types,O
.,O
origin,O
and,O
evo,O
‐,O
lution,O
of,O
human,O
Coronaviruses,MISC
(,O
CoVs,O
),O
belong,O
to,O
the,O
family,O
Coron,O
‐,O
aviridae,O
under,O
order,O
Nidovirales,O
.,O
The,O
family,O
Coronoviridae,O
has,O
two,NUMBER
How,O
to,O
cite,O
:,O
Alam,O
MS,STATE_OR_PROVINCE
.,O
Alam,O
MZ,O
.,O
Nazir,PERSON
KHMNH,PERSON
.,O
Bhuiyan,PERSON
MAB,PERSON
.,O
The,O
emergence,O
of,O
novel,O
coronavirus,O
disease,CAUSE_OF_DEATH
(,O
COVID,O
‐,O
19,NUMBER
),O
in,O
Bangladesh,COUNTRY
:,O
Present,DATE
status,O
.,O
challenges,O
and,O
future,DATE
management,O
.,O
J,PERSON
Adv,PERSON
Vet,PERSON
Anim,PERSON
Res,O
2020,DATE
;,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
subfamilies,O
.,O
such,O
as,O
Orthocoronaviridae,O
and,O
Torovirinae,O
.,O
The,O
subfamily,O
Orthocoronaviridae,O
has,O
four,NUMBER
genera,O
.,O
such,O
as,O
alphacoron,O
‐,O
avirus,O
.,O
betacoronavirus,O
.,O
gammacoronavirus,O
and,O
deltacoronavirus,O
[,O
10,NUMBER
],O
.,O
Until,O
now,DATE
.,O
seven,NUMBER
types,O
of,O
coronaviruses,O
have,O
the,O
ability,O
to,O
infect,O
human,O
.,O
The,O
human,O
coronaviruses,O
are,O
229E,O
.,O
NL63,O
.,O
OC43,O
and,O
HKU1,O
.,O
and,O
the,O
rarer,O
strains,O
are,O
SARS,O
‐,O
CoV,O
[,O
11,NUMBER
],O
and,O
Middle,O
Eastern,O
respiratory,O
syndrome,O
coronavirus,O
(,O
MERS,O
‐,O
CoV,O
),O
which,O
was,O
first,ORDINAL
ap,O
‐,O
peared,O
in,O
2012,DATE
in,O
Saudi,COUNTRY
Arabia,COUNTRY
[,O
12,NUMBER
],O
and,O
recent,O
SARSCoV,O
‐,O
2,NUMBER
[,O
13,NUMBER
],O
.,O
The,O
virus,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
has,O
a,O
single,O
‐,O
stranded,O
RNA,O
genome,O
ranged,O
from,O
26,NUMBER
to,O
32,NUMBER
kilobases,O
(,O
kb,O
),O
in,O
length,O
.,O
which,O
is,O
one,NUMBER
of,O
the,O
largest,O
genomes,O
among,O
RNA,O
viruses,O
[,O
14,NUMBER
],O
.,O
Ten,NUMBER
genome,O
sequences,O
of,O
SARS,O
‐,O
Cov,O
‐,O
2,NUMBER
exhibited,O
88,PERCENT
%,PERCENT
identity,O
with,O
two,NUMBER
bat,O
‐,O
derived,O
SARS,O
‐,O
like,O
coro,O
‐,O
naviruses,O
.,O
bat,O
‐,O
SL,O
‐,O
CoVZC45,O
and,O
bat,O
‐,O
SL,O
‐,O
CoVZXC21,O
;,O
however,O
.,O
they,O
were,O
more,O
distant,O
from,O
SARS,O
‐,O
CoV,O
(,O
about,O
79,PERCENT
%,PERCENT
),O
and,O
MERSCoV,O
about,O
50,PERCENT
%,PERCENT
[,O
15,NUMBER
],O
.,O
Usually,O
.,O
the,O
CoVs,O
are,O
commonly,O
harbored,O
in,O
mammals,O
and,O
birds,O
as,O
well,O
as,O
in,O
camels,O
.,O
cattle,O
.,O
cats,O
.,O
bats,O
.,O
and,O
other,O
animals,O
[,O
10,NUMBER
],O
.,O
Genomic,O
characterization,O
of,O
SARS,O
‐,O
CoV,O
.,O
MERS,O
‐,O
CoV,O
.,O
and,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
reported,O
that,O
the,O
origination,O
of,O
these,O
viruses,O
was,O
bats,O
.,O
The,O
intermediate,O
hosts,O
of,O
SARS,O
‐,O
CoV,O
and,O
MERS,O
‐,O
CoV,O
were,O
masked,O
palm,O
civets,O
and,O
dromedary,O
camels,O
.,O
respectively,O
.,O
with,O
human,O
as,O
terminal,O
hosts,O
[,O
16,NUMBER
],O
.,O
However,O
.,O
the,O
intermediate,O
hosts,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
are,O
predicted,O
to,O
be,O
the,O
unknown,O
wild,O
animals,O
sold,O
at,O
the,O
seafood,O
mar,DATE
‐,O
ket,O
[,O
16.17,NUMBER
],O
.,O
Worldwide,O
severity,O
and,O
outbreak,O
of,O
novel,O
human,O
coronavirus,O
(,O
COVID,O
‐,O
19,NUMBER
),O
A,O
new,O
type,O
of,O
pneumonia,CAUSE_OF_DEATH
was,O
detected,O
in,O
Wuhan,CITY
city,O
.,O
Hubei,STATE_OR_PROVINCE
Province,COUNTRY
of,COUNTRY
China,COUNTRY
.,O
on,O
31,DATE
December,DATE
2019,DATE
.,O
Since,O
then,O
.,O
a,O
total,O
of,O
44,NUMBER
cases,O
with,O
an,O
unknown,O
type,O
of,O
pneumonia,CAUSE_OF_DEATH
were,O
detected,O
until,O
3,DATE
January,DATE
2020,DATE
[,O
18.19,NUMBER
],O
.,O
The,O
outbreak,O
of,O
this,O
pneu,O
‐,O
monia,O
was,O
associated,O
with,O
exposures,O
in,O
one,NUMBER
seafood,O
market,O
.,O
The,O
unknown,O
case,O
was,O
confirmed,O
as,O
a,O
new,O
type,O
of,O
coronavirus,O
on,O
7,DATE
Jan,DATE
‐,O
uary,O
2020,DATE
.,O
Outside,O
of,O
China,COUNTRY
.,O
the,O
same,O
kind,O
of,O
novel,O
coronavirus,O
was,O
identified,O
on,O
13,NUMBER
.,O
15,NUMBER
.,O
and,NUMBER
20,NUMBER
January,DATE
2020,DATE
in,O
Thailand,COUNTRY
.,O
Japan,COUNTRY
.,O
and,O
the,O
Health,ORGANIZATION
Organization,ORGANIZATION
[,O
20,NUMBER
],O
.,O
the,O
cases,O
in,O
Thailand,COUNTRY
.,O
Japan,COUNTRY
.,O
City,O
.,O
China,COUNTRY
.,O
Officially,O
.,O
the,O
WHO,ORGANIZATION
has,O
named,O
the,O
novel,O
coronavirus,O
as,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
causing,O
coronavirus,O
disease,CAUSE_OF_DEATH
‐,O
2019,DATE
confirmed,O
case,O
(,O
a,O
person,O
with,O
laboratory,O
confirmation,O
),O
of,O
COVID,O
‐,O
19,NUMBER
was,O
282,NUMBER
(,O
claimed,O
six,NUMBER
lives,O
),O
.,O
which,O
had,O
skyrocketed,O
to,O
153.517,NUMBER
(,O
claimed,O
5735,NUMBER
lives,O
),O
on,O
15,DATE
March,DATE
2020,DATE
(,O
Fig.,O
1,NUMBER
),O
.,O
Due,O
to,O
the,O
severe,O
outbreak,O
across,O
the,O
globe,O
.,O
the,O
WHO,ORGANIZATION
declared,O
the,O
outbreak,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
pandemic,O
on,O
11,DATE
March,DATE
2020,DATE
[,O
8,NUMBER
],O
.,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
According,O
to,O
the,O
current,DATE
WHO,O
report,O
.,O
the,O
total,O
fatality,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
5.735,NUMBER
with,O
a,O
fatality,O
rate,O
of,O
only,O
3.73,PERCENT
%,PERCENT
[,O
8,NUMBER
],O
.,O
Howev,O
‐,O
er,O
.,O
overall,O
mortality,O
combinedly,O
caused,O
by,O
SARSCoV,O
and,O
MERS,O
‐,O
CoV,O
was,O
1632,DATE
[,O
21.22,NUMBER
],O
.,O
with,O
the,O
rate,O
of,O
occurrence,O
of,O
9.6,PERCENT
%,PERCENT
[,O
23,NUMBER
],O
and,O
35.2,PERCENT
%,PERCENT
[,O
2,NUMBER
],O
.,O
respectively,O
.,O
When,O
recorded,O
every,SET
day,SET
;,O
therefore,O
.,O
the,O
mortality,O
rate,O
of,O
COVID19,O
might,O
be,O
changing,O
.,O
which,O
could,O
not,O
be,O
calculated,O
accurately,O
until,O
the,O
end,O
of,O
this,O
outbreak,O
.,O
The,O
out,O
‐,O
break,O
of,O
COVID,O
‐,O
19,NUMBER
and,O
its,O
consequence,O
in,O
Three,NUMBER
confirmed,O
cases,O
of,O
COVID,O
‐,O
19,NUMBER
announced,O
for,O
the,O
of,O
epidemiology,O
.,O
disease,CAUSE_OF_DEATH
control,O
.,O
and,O
research,O
(,O
IEDCR,O
),O
.,O
Subsequently,O
.,O
there,O
were,O
no,O
confirmed,O
cases,O
found,O
on,O
13,DATE
March,DATE
2020,DATE
.,O
However,O
.,O
on,O
14,DATE
March,DATE
2020,DATE
.,O
two,NUMBER
more,O
con,O
‐,O
firmed,O
cases,O
newly,O
detected,O
in,O
Bangladesh,COUNTRY
.,O
Until,O
now,DATE
.,O
COVID,O
‐,O
19,NUMBER
caused,O
no,O
fatality,O
in,O
Bangladesh,COUNTRY
.,O
Among,O
the,O
and,O
Spain,COUNTRY
ranked,O
2nd,ORDINAL
.,O
3rd,ORDINAL
.,O
4th,ORDINAL
.,O
and,ORDINAL
5th,ORDINAL
.,O
respectively,O
.,O
after,O
China,COUNTRY
[,O
8,NUMBER
],O
(,O
Fig.,O
2,NUMBER
),O
.,O
In,O
comparison,O
to,O
the,O
global,O
perspective,O
.,O
although,O
the,O
occurrence,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
very,O
low,O
(,O
only,O
0.003,PERCENT
%,PERCENT
),O
in,O
Bangladesh,COUNTRY
.,O
the,O
panic,O
which,O
spreads,O
among,O
the,O
most,O
densely,O
populated,O
country,O
(,O
160,NUMBER
million,NUMBER
people,O
),O
in,O
the,O
world,O
is,O
immense,O
.,O
The,O
first,ORDINAL
blow,O
of,O
this,O
panic,O
hits,O
into,O
the,O
Bangladesh,COUNTRY
stock,O
market,O
;,O
due,O
to,O
the,O
fear,O
selling,O
.,O
the,O
general,TITLE
index,O
of,O
the,O
DSE,ORGANIZATION
plunged,O
279.32,NUMBER
points,O
(,O
6.51,PERCENT
%,PERCENT
),O
to,O
close,O
the,DATE
day,DATE
at,O
4.008.05,NUMBER
[,O
24,NUMBER
],O
.,O
The,O
panic,O
also,O
affected,O
foreign,O
trade,O
.,O
Qatar,COUNTRY
temporarily,O
barred,O
travelers,O
from,O
Bangladesh,COUNTRY
.,O
The,O
Prime,TITLE
Minister,TITLE
of,O
India,COUNTRY
.,O
Narendra,PERSON
Modi,PERSON
.,O
has,O
canceled,O
his,O
trip,O
to,O
Bangladesh,COUNTRY
on,O
the,O
occasion,O
of,O
grand,O
inaugural,O
ceremony,O
of,O
Mujib,PERSON
Year,DURATION
[,O
25,NUMBER
],O
.,O
and,O
there,O
is,O
excessive,O
price,O
gouging,O
of,O
some,O
essen,O
‐,O
tials,O
such,O
as,O
infected,O
countries,O
and,O
Bangladesh,COUNTRY
with,O
a,O
percentage,O
share,O
of,O
global,O
cases,O
as,O
of,O
16,DATE
March,DATE
2020,DATE
.,O
(,O
Source,O
:,O
WHO,O
;,O
situa,O
‐,O
tion,O
report,O
surgical,O
and,O
face,O
masks,O
.,O
sanitizers,O
.,O
electronics,O
and,O
electrical,O
materials,O
.,O
and,O
so,O
on,O
.,O
[,O
26,NUMBER
],O
.,O
The,O
Government,O
on,O
14,DATE
March,DATE
2020,DATE
declared,O
that,O
no,O
inbound,O
passengers,O
from,O
European,NATIONALITY
countries,O
except,O
the,O
UK,COUNTRY
would,O
be,O
allowed,O
in,O
Bangladesh,COUNTRY
until,O
31,DATE
March,DATE
2020,DATE
.,O
All,O
kinds,O
of,O
on,O
‐,O
arrival,O
visas,O
have,O
been,O
suspended,O
for,O
new,O
2,NUMBER
weeks,DURATION
.,O
Besides,O
.,O
passengers,O
return,O
from,O
any,O
country,O
would,O
be,O
self,O
‐,O
quarantined,O
for,O
14,DURATION
days,DURATION
[,O
27,NUMBER
],O
.,O
Still,O
.,O
any,O
relaxation,O
on,O
monitoring,O
this,O
disease,CAUSE_OF_DEATH
would,O
be,O
very,O
costly,O
.,O
All,O
kinds,O
of,O
educational,O
in,O
‐,O
stitutions,O
would,O
remain,O
close,O
until,O
31,DATE
March,DATE
2020,DATE
[,O
27,NUMBER
],O
.,O
Moreover,O
.,O
all,O
sports,O
activities,O
to,O
be,O
postponed,O
until,O
31,DATE
March,DATE
2020,DATE
[,O
27,NUMBER
],O
.,O
Unlike,O
the,O
USA,COUNTRY
.,O
Spain,COUNTRY
.,O
Serbia,COUNTRY
.,O
France,COUNTRY
.,O
and,O
Lebanon,COUNTRY
.,O
Bangladesh,COUNTRY
has,O
yet,O
to,O
declare,O
a,O
state,O
of,O
emergency,O
.,O
The,O
country,O
is,O
now,DATE
in,O
a,O
state,O
of,O
uncertainty,O
.,O
just,O
watching,O
the,O
global,O
initiatives,O
.,O
The,O
Prime,TITLE
Minister,TITLE
(,O
PM,O
),O
of,O
Bangladesh,COUNTRY
has,O
promptly,O
accepted,O
the,O
pres,O
‐,O
ence,O
and,O
reality,O
of,O
COVID,O
‐,O
19,NUMBER
in,O
to,O
closely,O
monitor,O
the,O
situation,O
at,O
all,O
the,O
entry,O
points,O
of,O
Bangladesh,COUNTRY
and,O
to,O
improve,O
the,O
facili,O
‐,O
ties,O
of,O
all,O
the,O
public,O
hospitals,O
by,O
ensuring,O
enough,O
quarantine,O
facilities,O
.,O
The,O
PM,O
also,O
canceled,O
all,O
the,O
prescheduled,O
meetings,O
.,O
processions,O
.,O
public,O
gatherings,O
.,O
and,O
foreign,O
trips,O
.,O
Epidemiology,O
of,O
COVID,O
‐,O
19,NUMBER
Environmental,O
factors,O
such,O
as,O
temperature,O
.,O
humidity,O
.,O
and,O
wind,O
speed,O
have,O
a,O
significant,O
effect,O
on,O
the,O
survival,O
and,O
transmission,O
of,O
human,O
coronaviruses,O
such,O
as,O
SARSCoV,O
and,O
MERS,O
‐,O
CoV,O
[,O
28,NUMBER
],O
.,O
In,O
general,TITLE
.,O
the,O
survival,O
of,O
viral,O
SARS,O
‐,O
CoV,O
could,O
survive,O
for,O
5,DURATION
days,DURATION
on,O
a,O
smooth,O
surface,O
at,O
22C25C,O
and,O
relative,O
humidity,O
40,PERCENT
%,PERCENT
50,PERCENT
%,PERCENT
[,O
28,NUMBER
],O
.,O
However,O
.,O
it,O
is,O
lost,O
its,O
activity,O
with,O
the,O
increase,O
of,O
temperature,O
and,O
relative,O
humidity,O
at,O
38C,O
and,O
95,PERCENT
%,PERCENT
.,O
respective,O
‐,O
ly,O
.,O
The,O
possible,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
has,O
occurred,O
through,O
airborne,O
droplets,O
.,O
Furthermore,O
.,O
this,O
virus,O
could,O
survive,O
in,O
human,O
feces,O
[,O
30,NUMBER
],O
.,O
Another,O
human,O
coronavirus,O
MERS,O
‐,O
CoV,O
could,O
remain,O
ac,O
‐,O
tive,O
for,O
an,O
extended,O
period,O
as,O
droplets,O
on,O
the,O
solid,O
surface,O
at,O
high,O
temperature,O
(,O
15C35C,O
),O
and,O
low,O
humidity,O
(,O
<,O
20,PERCENT
%,PERCENT
),O
.,O
However,O
.,O
with,O
the,O
increase,O
of,O
relative,O
humidity,O
(,O
>,O
35,PERCENT
%,PERCENT
),O
and,O
temperatures,O
(,O
5C15C,O
),O
.,O
the,O
survivability,O
and,O
spread,O
of,O
MERS,O
‐,O
CoV,O
would,O
be,O
re,O
‐,O
duced,O
[,O
31,NUMBER
],O
.,O
Although,O
newly,O
emerged,O
novel,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
virus,O
has,O
similar,O
origin,O
with,O
SARS,O
‐,O
CoV,O
and,O
MERS,O
‐,O
CoV,O
.,O
the,O
role,O
of,O
tempera,O
‐,O
ture,O
and,O
absolute,O
humidity,O
in,O
the,O
transmission,O
is,O
yet,O
to,O
be,O
clearly,O
understood,O
.,O
The,O
contradictory,O
reports,O
have,O
scientists,O
in,O
China,COUNTRY
[,O
32,NUMBER
],O
reported,O
that,O
the,O
increased,O
temperature,O
and,O
humidity,O
did,O
not,O
reduce,O
the,O
incidence,O
of,O
COVID,O
‐,O
19,NUMBER
[,O
32,NUMBER
],O
.,O
However,O
.,O
according,O
to,O
Wang,PERSON
et,O
al.,O
[,O
29,NUMBER
],O
.,O
the,O
increased,O
temperate,O
and,O
relative,O
humidi,O
‐,O
ty,O
significantly,O
reduced,O
the,O
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
in,O
100,NUMBER
cities,O
of,O
China,COUNTRY
.,O
Similarly,O
.,O
another,O
group,O
reported,O
that,O
the,O
COVID,O
‐,O
19,NUMBER
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
virus,O
is,O
sensitive,O
to,O
high,O
temperatures,O
(,O
>,O
30C,NUMBER
),O
[,O
33,NUMBER
],O
.,O
Using,O
the,O
current,DATE
statistics,O
available,O
in,O
situation,O
report,O
55,NUMBER
at,O
the,O
WHO,O
website,O
[,O
8,NUMBER
],O
.,O
the,O
cumulative,O
rate,O
of,O
confirmed,O
cases,O
and,O
deaths,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
1.4,PERCENT
%,PERCENT
and,O
0.52,PERCENT
%,PERCENT
.,O
respectively,O
.,O
in,O
tropical,O
or,O
subtrop,O
‐,O
ical,O
countries,O
or,O
regions,O
.,O
but,O
it,O
is,O
98.59,PERCENT
%,PERCENT
and,O
99.47,PERCENT
%,PERCENT
.,O
respec,O
‐,O
tively,O
.,O
in,O
temperate,O
countries,O
or,O
subtropical,O
and,O
temperate,O
re,O
‐,O
gions,O
/,O
countries,O
.,O
Tropical,O
/,O
subtropical,O
countries,O
or,O
regions,O
Tem,O
‐,O
perate,O
countries,O
or,O
regions,O
Confirmed,O
cases,O
Confirmed,O
cases,O
Saudi,NATIONALITY
Arabia,LOCATION
Sri,COUNTRY
Lanka,COUNTRY
United,COUNTRY
Kingdom,COUNTRY
United,COUNTRY
States,COUNTRY
of,O
Total,O
Confirmed,O
cases,O
Total,O
deaths,O
Percent,O
of,O
confirmed,O
cases,O
in,O
tropical,O
/,O
sub,O
‐,O
tropical,O
countries,O
/,O
regions,O
Percent,O
of,O
confirmed,O
cases,O
in,O
temper,O
‐,O
ate,O
countries,O
/,O
regions,O
Percent,O
of,O
death,O
in,O
tropical,O
/,O
subtropical,O
countries,O
/,O
regions,O
Percent,O
of,O
death,O
in,O
temperate,O
countries,O
/,O
regions,O
Up,O
to,O
16,DATE
March,DATE
2020,DATE
[,O
8,NUMBER
],O
.,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
and,O
deaths,O
in,O
different,O
climatic,O
regions,O
are,O
caused,O
by,O
the,O
variation,O
of,O
temperature,O
and,O
relative,O
humidity,O
in,O
these,O
countries,O
or,O
regions,O
.,O
Although,O
the,O
mechanism,O
of,O
trans,O
‐,O
mission,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
not,O
fully,O
understood,O
.,O
the,O
recent,O
studies,O
of,O
Huang,PERSON
et,O
al,O
.,O
[,O
34,NUMBER
],O
and,O
Chan,PERSON
et,O
al.,O
[,O
35,NUMBER
],O
have,O
reported,O
human,O
‐,O
to,O
‐,O
human,O
transmission,O
through,O
the,O
respiratory,O
droplets,O
and,O
sur,O
‐,O
face,O
contact,O
.,O
The,O
droplets,O
are,O
generated,O
from,O
the,O
infected,O
person,O
through,O
his,O
coughs,O
or,O
sneezes,O
.,O
which,O
could,O
potentially,O
infect,O
others,O
remaining,O
in,O
close,O
contact,O
[,O
36,NUMBER
],O
.,O
The,O
virus,O
within,O
the,O
droplets,O
could,O
remain,O
viable,O
on,O
the,O
surface,O
of,O
an,O
object,O
for,O
a,O
few,DURATION
days,DURATION
;,O
thus,O
.,O
the,O
nearby,O
surroundings,O
of,O
an,O
infected,O
person,O
are,O
potential,O
sources,O
of,O
contamination,O
.,O
The,O
symptomatic,O
(,O
sickest,O
),O
persons,O
are,O
thought,O
to,O
be,O
most,O
contagious,O
.,O
Moreover,O
.,O
recent,O
evi,O
‐,O
dence,O
suggests,O
that,O
a,O
person,O
without,O
symptoms,O
(,O
asymptomatic,O
),O
could,O
potentially,O
spread,O
the,O
pathogen,O
during,O
the,O
incubation,O
peri,O
‐,O
od,O
[,O
37,NUMBER
],O
.,O
Unlike,O
SARS,O
virus,O
.,O
the,O
risk,O
of,O
contamination,O
by,O
COVID19,O
virus,O
through,O
feces,O
of,O
an,O
infected,O
person,O
is,O
low,O
[,O
34,NUMBER
],O
.,O
Besides,O
.,O
there,O
is,O
no,O
evidence,O
of,O
airborne,O
dissemination,O
of,O
The,O
subtropical,O
monsoon,O
climate,O
in,O
Bangladesh,COUNTRY
is,O
characterized,O
by,O
heavy,O
summer,DATE
rainfall,O
and,O
high,O
summer,DATE
temperature,O
with,O
often,O
excessive,O
humidi,O
‐,O
ty,O
.,O
The,O
range,O
of,O
ambient,O
temperature,O
in,O
the,O
summer,DATE
is,O
36C40C,O
.,O
and,O
winter,DATE
temperature,O
is,O
8C15C,O
[,O
38,NUMBER
],O
.,O
If,O
the,O
studies,O
of,O
Wang,PERSON
et,O
al,O
.,O
[,O
29.33,NUMBER
],O
are,O
true,O
and,O
if,O
the,O
trend,O
of,O
disease,CAUSE_OF_DEATH
occurrence,O
particu,O
‐,O
larly,O
in,O
the,O
summer,DATE
season,O
.,O
Although,O
the,O
mechanism,O
of,O
high,O
tem,O
‐,O
perature,O
and,O
high,O
humidity,O
reduces,O
the,O
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
not,O
known,O
yet,O
.,O
in,O
the,O
case,O
of,O
temperatures,O
.,O
and,O
respiratory,O
droplets,O
remain,O
airborne,O
longer,O
in,O
dry,O
air,O
[,O
39.40,NUMBER
],O
.,O
Second,ORDINAL
.,O
cold,O
and,O
dry,O
weather,O
impairs,O
mucociliary,O
clearance,O
.,O
innate,O
antiviral,O
immunity,O
.,O
and,O
tissue,O
repair,O
and,O
makes,O
them,O
more,O
susceptible,O
to,O
the,O
virus,O
[,O
41.42,NUMBER
],O
.,O
These,O
mechanisms,O
are,O
also,O
likely,O
to,O
applicable,O
for,O
the,O
COVID,O
‐,O
19,NUMBER
transmission,O
.,O
Pathogenesis,O
of,O
COVID,O
‐,O
19,NUMBER
The,O
clinical,O
signs,O
and,O
symptoms,O
are,O
almost,O
similar,O
to,O
that,O
of,O
SARS,O
and,O
MERS,O
infections,CAUSE_OF_DEATH
[,O
43,NUMBER
],O
.,O
Hence,O
.,O
although,O
the,O
pathogenesis,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
poorly,O
understood,O
.,O
the,O
similar,O
mechanisms,O
of,O
SARS,O
and,O
MERS,O
still,O
can,O
give,O
us,O
a,O
lot,O
of,O
information,O
on,O
the,O
pathogenesis,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
The,O
lungs,O
are,O
made,O
up,O
of,O
a,O
mass,O
of,O
alveoli,O
.,O
The,O
alveoli,O
are,O
responsible,O
for,O
gaseous,O
exchange,O
.,O
providing,O
oxygen,O
to,O
blood,O
flowing,O
through,O
capillaries,O
in,O
the,O
alveolar,O
membrane,O
.,O
The,O
alveolar,O
walls,O
are,O
composed,O
of,O
type,O
I,NUMBER
and,O
type,O
II,NUMBER
pneumocytes,O
.,O
along,O
with,O
alveolar,O
macrophages,O
(,O
Fig.,O
3,NUMBER
),O
[,O
44,NUMBER
],O
.,O
Type,O
I,NUMBER
pneumocytes,O
are,O
responsible,O
for,O
gaseous,O
exchange,O
with,O
blood,O
in,O
the,O
capillar,O
‐,O
ies,O
of,O
the,O
lungs,O
.,O
Type,O
II,NUMBER
pneumocytes,O
are,O
the,O
progenitors,O
of,O
type,O
I,O
pneumocytes,O
and,O
are,O
also,O
responsible,O
for,O
producing,O
surfactant,O
[,O
45,NUMBER
],O
.,O
SARS,O
‐,O
CoV,O
infection,CAUSE_OF_DEATH
causes,O
desquamation,O
of,O
pneumocytes,O
by,O
releasing,O
inflammatory,O
cytokine,O
in,O
humans,O
and,O
rats,O
and,O
alveolar,O
swelling,O
.,O
edema,O
.,O
and,O
hemorrhage,CAUSE_OF_DEATH
in,O
the,O
lungs,O
(,O
Fig.,O
3,NUMBER
),O
[,O
46,NUMBER
],O
.,O
The,O
virus,O
also,O
destroys,O
alveolar,O
macrophages,O
that,O
play,O
an,O
essential,O
role,O
in,O
local,O
immune,O
response,O
[,O
47,NUMBER
],O
.,O
In,O
critical,O
illness,CAUSE_OF_DEATH
.,O
uncon,O
‐,O
trolled,O
inflammation,O
.,O
fluid,O
accumulation,O
.,O
and,O
developing,O
fibrosis,O
severely,O
compromise,O
gas,O
exchange,O
and,O
lead,O
to,O
respiratory,CAUSE_OF_DEATH
failure,CAUSE_OF_DEATH
[,O
42,NUMBER
],O
.,O
Symptoms,O
of,O
COVID,O
‐,O
19,NUMBER
The,O
symptoms,O
of,O
COVID,O
‐,O
19,NUMBER
are,O
either,O
asymptomatic,O
(,O
no,O
signs,O
),O
or,O
symptomatic,O
(,O
non,O
‐,O
.,O
mild,O
‐,O
.,O
or,O
severe,O
pneumonia,CAUSE_OF_DEATH
),O
[,O
48,NUMBER
],O
.,O
The,O
range,O
of,O
mild,O
disease,CAUSE_OF_DEATH
(,O
i.e.,O
.,O
nonpneumonia,O
or,O
mild,O
pneumonia,CAUSE_OF_DEATH
),O
is,O
about,O
80,PERCENT
%,PERCENT
of,O
cases,O
(,O
mostly,O
curable,O
),O
.,O
mildto,O
‐,O
severe,O
pneumonia,CAUSE_OF_DEATH
is,O
about,O
14,PERCENT
%,PERCENT
.,O
and,O
critical,O
illness,CAUSE_OF_DEATH
is,O
about,O
6,PERCENT
%,PERCENT
of,O
cases,O
[,O
22,NUMBER
],O
.,O
The,O
critical,O
illnesses,O
lead,O
to,O
severe,O
consequences,O
such,O
as,O
a,O
death,O
in,O
the,O
case,O
of,O
the,O
elderly,O
or,O
other,O
people,O
who,O
have,O
severe,O
chronic,O
medical,O
conditions,O
such,O
as,O
heart,CAUSE_OF_DEATH
disease,CAUSE_OF_DEATH
.,O
di,O
‐,O
abetes,O
.,O
and,O
lung,O
diseases,CAUSE_OF_DEATH
[,O
15,NUMBER
],O
.,O
Other,O
common,O
signs,O
of,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
are,O
respiratory,O
symptoms,O
.,O
fever,CAUSE_OF_DEATH
.,O
coughing,O
.,O
sneezing,O
.,O
shortness,O
of,O
breath,O
.,O
Diagnosis,O
of,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
As,O
there,O
are,O
no,O
specific,O
therapeutic,O
drugs,CRIMINAL_CHARGE
or,O
vaccines,O
available,O
for,O
novel,O
COVID,O
‐,O
19,NUMBER
;,O
therefore,O
.,O
it,O
is,O
essential,O
to,O
detect,O
the,O
disease,CAUSE_OF_DEATH
at,O
an,O
early,O
stage,O
so,O
that,O
immediate,O
isolation,O
of,O
the,O
patient,O
could,O
be,O
undertaken,O
.,O
Thus,O
.,O
the,O
radiological,O
examination,O
is,O
used,O
for,O
the,O
early,O
detection,O
of,O
COVID,O
‐,O
19,NUMBER
[,O
49,NUMBER
],O
.,O
Thin,O
‐,O
slice,O
chest,O
CT,STATE_OR_PROVINCE
functions,O
are,O
more,O
effectively,O
detecting,O
pneumonia,CAUSE_OF_DEATH
caused,O
by,O
COVID,O
‐,O
19,NUMBER
at,O
a,O
very,O
early,O
stage,O
[,O
50,NUMBER
],O
.,O
The,O
sensitivity,O
of,O
CT,STATE_OR_PROVINCE
for,O
COVID,O
‐,O
19,NUMBER
infec,O
‐,O
tion,O
was,O
98,PERCENT
%,PERCENT
.,O
but,O
it,O
was,O
much,O
higher,O
than,O
the,O
sensitivity,O
(,O
71,PERCENT
%,PERCENT
;,O
p,O
<,O
0.001,NUMBER
),O
of,O
RT,O
‐,O
PCR,O
[,O
49.51,NUMBER
],O
.,O
Although,O
nucleic,O
acid,O
‐,O
based,O
(,O
3,PERCENT
%,PERCENT
),O
pa,O
‐,O
tients,O
.,O
who,O
had,O
negative,O
RT,O
‐,O
qPCR,O
for,O
COVID,O
‐,O
19,NUMBER
at,O
the,O
initial,O
stage,O
of,O
COVID,O
‐,O
19,NUMBER
but,O
conduction,O
of,O
chest,O
CT,STATE_OR_PROVINCE
.,O
confirmed,O
viral,O
pneumonia,CAUSE_OF_DEATH
at,O
the,O
early,O
stage,O
.,O
The,O
collection,O
of,O
samples,O
for,O
the,O
detection,O
of,O
the,O
virus,O
is,O
a,O
big,O
challenge,O
for,O
the,O
health,O
workers,O
.,O
The,O
recommended,O
specimens,O
for,O
COVID,O
‐,O
19,NUMBER
diagnosis,O
are,O
nasopharyn,O
‐,O
geal,O
and,O
oropharyngeal,O
swabs,O
;,O
however,O
.,O
the,O
collection,O
of,O
these,O
samples,O
requires,O
close,O
contact,O
with,O
the,O
patients,O
.,O
which,O
poses,O
a,O
risk,O
of,O
transmission,O
of,O
the,O
viruses,O
to,O
the,O
healthcare,O
personnel,O
.,O
Therefore,O
.,O
saliva,O
specimens,O
are,O
suggested,O
because,O
patients,O
could,O
easily,O
spit,O
their,O
saliva,O
into,O
a,O
sterile,O
bottle,O
in,O
a,O
noninvasive,O
way,O
[,O
53,NUMBER
],O
.,O
Meanwhile,O
.,O
real,O
‐,O
time,O
RT,O
‐,O
PCR,O
using,O
blood,O
samples,O
gave,O
a,O
very,O
low,O
percentage,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
and,O
resident,O
alveolar,O
macrophages,O
and,O
pulmonary,O
surfactant,O
exist,O
in,O
the,O
airspace,O
(,O
A,O
),O
.,O
In,O
the,O
acute,O
phase,O
of,O
SARS,O
‐,O
CoV,O
infection,CAUSE_OF_DEATH
(,O
B,O
),O
.,O
type,O
I,NUMBER
and,O
type,O
II,NUMBER
pneumocytes,O
are,O
infected,O
and,O
secrete,O
in,O
‐,O
flammatory,O
cytokines,O
.,O
whereas,O
surfactant,O
levels,O
decrease,O
.,O
In,O
se,O
‐,O
vere,O
illness,CAUSE_OF_DEATH
.,O
inflammation,O
.,O
fluid,O
accumulation,O
.,O
and,O
developing,O
fibrosis,O
severely,O
damage,O
alveoli,O
and,O
lead,O
to,O
respiratory,CAUSE_OF_DEATH
failure,CAUSE_OF_DEATH
(,O
C,O
),O
.,O
Clinical,O
signs,O
and,O
Zoonotic,MISC
transmission,O
Incubation,O
period,O
Bats,O
harbor,O
the,O
three,NUMBER
coronaviruses,O
as,O
a,O
reservoir,O
host,TITLE
.,O
It,O
is,O
still,O
unclear,O
whether,O
the,O
COVID,O
‐,O
19,NUMBER
transmitted,O
from,O
bats,O
to,O
hu,O
‐,O
mans,O
[,O
10,NUMBER
],O
.,O
Then,O
.,O
humanto,O
‐,O
human,O
transmission,O
through,O
droplets,O
.,O
personal,O
(,O
handshaking,O
),O
.,O
and,O
contaminated,O
surface,O
contact,O
[,O
34.35,NUMBER
],O
.,O
It,O
seems,O
to,O
be,O
more,O
transmissible,O
than,O
SARS,O
and,O
214,DURATION
days,DURATION
[,O
10.55,NUMBER
],O
Mostly,O
respiratory,O
symptoms,O
.,O
such,O
as,O
fever,CAUSE_OF_DEATH
.,O
dry,O
cough,O
.,O
shortness,O
of,O
breath,O
.,O
and,O
in,O
the,O
most,O
severe,O
cases,O
.,O
have,O
pneumonia,CAUSE_OF_DEATH
[,O
10,NUMBER
],O
Pri,O
‐,O
marily,O
transmitted,O
from,O
bats,O
to,O
snakes,O
.,O
civet,O
cats,O
.,O
and,O
finally,O
to,O
human,O
[,O
10,NUMBER
],O
.,O
Then,O
.,O
similar,O
transmission,O
to,O
COVID,O
‐,O
19,NUMBER
.,O
including,O
fecal,O
[,O
34.60,NUMBER
],O
.,O
210,DURATION
days,DURATION
.,O
up,DURATION
to,DURATION
14,DURATION
days,DURATION
[,O
10,NUMBER
],O
Primarily,O
transmit,O
‐,O
ted,O
from,O
bats,O
to,O
camels,O
and,O
finally,O
to,O
human,O
[,O
10,NUMBER
],O
and,O
then,O
human,O
to,O
human,O
transmission,O
via,O
direct,O
respiratory,O
secretion,O
contact,O
[,O
34,NUMBER
],O
and,O
also,O
fecal,O
‐,O
oral,O
transmission,O
[,O
60,NUMBER
],O
.,O
days,DURATION
[,O
10,NUMBER
],O
Clinical,O
diagnosis,O
based,O
on,O
symptoms,O
.,O
history,O
and,O
chest,O
imaging,O
.,O
and,O
diag,O
‐,O
nosis,O
by,O
nucleic,O
acid,O
test,O
.,O
such,O
as,O
RT,O
‐,O
qPCR,O
.,O
deep,O
sequencing,O
.,O
and,O
ELISA,ORGANIZATION
[,O
34.56,NUMBER
],O
.,O
No,O
antiviral,O
drug,O
yet,O
[,O
57.58,NUMBER
],O
.,O
Oxygen,O
and,O
fluid,O
therapy,O
and,O
antibiotics,O
with,O
oseltamivir,O
[,O
34.57.58,NUMBER
],O
.,O
In,O
severe,O
illness,CAUSE_OF_DEATH
.,O
corticosteroids,O
are,O
used,O
to,O
reduce,O
lung,O
inflammation,O
[,O
59,NUMBER
],O
.,O
Besides,O
respiratory,O
Similar,O
to,O
COVID,O
‐,O
19,NUMBER
symptoms,O
[,O
10,NUMBER
],O
.,O
the,O
virus,O
is,O
known,O
to,O
cause,O
enteric,O
symptom,O
.,O
such,O
as,O
diarrhea,O
and,O
ab,O
‐,O
dominal,O
pain,O
.,O
and,O
finally,O
focal,O
necrosis,O
and,O
nephritis,CAUSE_OF_DEATH
in,O
the,O
kidney,O
[,O
60,NUMBER
],O
.,O
Similar,O
to,O
COVID,O
‐,O
19,NUMBER
Severe,O
acute,O
respiratory,O
dis,O
‐,O
tress,O
.,O
severe,O
pneumonia,CAUSE_OF_DEATH
.,O
enteric,O
symptoms,O
.,O
and,O
kidney,CAUSE_OF_DEATH
failure,CAUSE_OF_DEATH
[,O
60.61,NUMBER
],O
.,O
Similar,O
to,O
COVID,O
‐,O
19,NUMBER
Similar,O
to,O
COVID,O
‐,O
19,NUMBER
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
(,O
1,PERCENT
%,PERCENT
),O
of,O
the,O
positive,O
results,O
.,O
and,O
urine,O
samples,O
did,O
not,O
give,O
pos,O
‐,O
itive,O
results,O
[,O
54,NUMBER
],O
.,O
which,O
provides,O
the,O
diagnostic,O
facilities,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
The,O
detection,O
of,O
COVID,O
‐,O
19,NUMBER
is,O
a,O
real,O
‐,O
time,O
RT,O
‐,O
PCR,O
‐,O
based,O
assay,O
that,O
requires,O
skilled,O
human,O
resources,O
and,O
sophisticated,O
laboratory,O
facilities,O
.,O
To,O
avoid,O
false,O
results,O
and,O
risks,O
of,O
bio,O
‐,O
logical,O
hazards,O
.,O
the,O
Government,O
is,O
not,O
allowing,O
any,O
other,O
private,O
organizations,O
except,O
IEDCR,O
to,O
perform,O
this,O
[,O
27,NUMBER
],O
.,O
The,O
rapid,O
test,O
kits,O
are,O
although,O
available,O
in,O
Bangladesh,COUNTRY
.,O
but,O
the,O
WHO,ORGANIZATION
does,O
not,O
approve,O
these,O
kits,O
.,O
Prevention,O
and,O
control,O
of,O
COVID,O
‐,O
19,NUMBER
It,O
is,O
popularly,O
said,O
that,O
prevention,O
is,O
better,O
than,O
cure,O
.,O
Prevention,O
of,O
COVID,O
‐,O
19,NUMBER
should,O
be,O
the,O
prime,O
strategy,O
to,O
restrict,O
this,O
deadly,O
disease,CAUSE_OF_DEATH
from,O
a,O
further,O
outbreak,O
in,O
Bangladesh,COUNTRY
.,O
The,O
WHO,ORGANIZATION
suggested,O
that,O
the,O
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
should,O
be,O
prevented,O
by,O
reducing,O
the,O
secondary,O
infections,CAUSE_OF_DEATH
among,O
close,O
contact,O
with,O
persons,O
who,O
suffer,O
from,O
acute,O
respiratory,CAUSE_OF_DEATH
infections,CAUSE_OF_DEATH
.,O
Besides,O
.,O
the,O
hands,O
should,O
be,O
frequently,O
washed,O
after,O
direct,O
contact,O
with,O
a,O
sick,O
per,O
‐,O
son,O
;,O
furthermore,O
.,O
the,O
unprotected,O
contact,O
with,O
wild,O
animals,O
should,O
be,O
avoided,O
.,O
Moreover,O
.,O
the,O
COVID,O
‐,O
19infected,O
person,O
should,O
maintain,O
a,O
good,O
practice,O
of,O
cough,O
etiquettes,O
such,O
as,O
by,O
covering,O
coughs,O
and,O
sneezes,O
with,O
disposable,O
tissues,O
or,O
clean,O
clothes,O
.,O
by,O
washing,O
hands,O
.,O
and,O
by,O
maintaining,O
distance,O
with,O
noninfected,O
per,O
‐,O
sons,O
[,O
15,NUMBER
],O
.,O
In,O
addition,O
to,O
these,O
preventive,O
measures,O
.,O
the,O
Govern,O
‐,O
ment,O
of,O
Bangladesh,COUNTRY
should,O
be,O
undertaken,O
stern,O
actions,O
against,O
the,O
passengers,O
.,O
such,O
as,O
strictly,O
measuring,O
their,O
body,O
temperature,O
or,O
keep,O
them,O
in,O
an,O
isolation,O
condition,O
for,O
14,DURATION
days,DURATION
at,O
the,O
land,O
.,O
sea,O
.,O
and,O
airports,O
after,O
arrival,O
from,O
COVID,O
‐,O
19infected,O
countries,O
.,O
Ef,O
‐,O
fective,O
vaccines,O
are,O
essential,O
to,O
control,O
the,O
coronavirus,O
out,O
‐,O
breaks,O
.,O
There,O
are,O
several,O
vaccination,O
strategies,O
used,O
against,O
SARS,O
‐,O
CoV,O
.,O
and,O
MERS,O
‐,O
CoV,O
tested,O
in,O
animals,O
.,O
including,O
a,O
live,O
‐,O
atten,O
‐,O
uated,O
virus,O
.,O
inactivated,O
virus,O
.,O
subunit,O
vaccines,O
.,O
recombinant,O
DNA,O
.,O
and,O
protein,O
vaccines,O
[,O
62,NUMBER
],O
.,O
These,O
studies,O
are,O
still,O
underway,O
to,O
develop,O
vaccines,O
for,O
Unlike,O
SARS,O
‐,O
CoV,O
and,O
MERS,O
‐,O
CoV,O
.,O
no,O
proven,O
vaccines,O
so,O
far,O
discovered,O
against,O
COVID,O
‐,O
19,NUMBER
.,O
However,O
.,O
the,O
first,ORDINAL
trial,O
of,O
evaluating,O
a,O
vaccine,O
against,O
COVID,O
‐,O
19,NUMBER
has,O
begun,O
on,O
15,NUMBER
March,DATE
2020,DATE
at,O
kaiser,O
permanente,O
washington,STATE_OR_PROVINCE
health,O
promising,O
tar,O
‐,O
gets,O
for,O
COVID,O
‐,O
19,NUMBER
.,O
but,O
more,O
clinical,O
trials,O
still,O
should,O
be,O
need,O
‐,O
ed,O
.,O
Management,O
of,O
COVID,O
‐,O
19,NUMBER
contamination,O
Evidence,O
suggests,O
that,O
the,O
virus,O
is,O
contaminated,O
from,O
human,O
to,O
human,O
very,O
rapidly,O
[,O
35.64,NUMBER
],O
.,O
Although,O
complete,O
elimination,O
of,O
COVID,O
‐,O
19,NUMBER
outbreak,O
seems,O
impossible,O
.,O
several,O
key,O
measures,O
could,O
reduce,O
the,O
possible,O
trans,O
‐,O
mission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
by,O
avoiding,O
the,O
contact,O
opportunities,O
of,O
outbreak,O
.,O
traveling,O
and,O
trade,O
restrictions,O
.,O
entry,O
screening,O
of,O
the,O
travelers,O
during,O
outbreak,O
period,O
.,O
isolation,O
of,O
infected,O
cas,O
‐,O
es,O
.,O
and,O
maintaining,O
the,O
physical,O
distance,O
within,O
the,O
workspace,O
.,O
In,O
this,O
backdrop,O
.,O
flexible,O
working,O
schedules,O
/,O
shifts,O
for,O
employ,O
‐,O
ees,O
.,O
the,O
opportunity,O
of,O
distance,O
working,O
/,O
teleworking,O
.,O
increased,O
use,O
of,O
email,O
and,O
teleconferences,O
to,O
reduce,O
close,O
contacts,O
.,O
re,O
‐,O
duced,O
contact,O
between,O
employees,O
and,O
customers,O
.,O
reduced,O
contact,O
between,O
employees,O
.,O
promoting,O
the,O
use,O
of,O
other,O
personal,O
protective,O
countermeasures,O
.,O
and,O
avoiding,O
mass,O
gathering,O
.,O
such,O
as,O
sport,O
events,O
.,O
concerts,O
.,O
religious,O
events,O
.,O
conferences,O
.,O
and,O
so,O
on,O
are,O
advised,O
.,O
According,O
to,O
the,O
WHO,ORGANIZATION
.,O
the,O
practice,O
of,O
good,O
personal,O
hy,O
‐,O
giene,O
is,O
essential,O
[,O
8.66,NUMBER
],O
.,O
Regularly,O
washing,O
hands,O
with,O
soaps,O
and,O
water,O
and,O
avoid,O
touching,O
the,O
face,O
with,O
the,O
hands,O
are,O
some,O
ways,O
to,O
ensure,O
personal,O
hygiene,O
.,O
Wearing,O
a,O
mask,O
is,O
not,O
essential,O
until,O
a,O
person,O
is,O
detected,O
with,O
SARSCoV,O
‐,O
2,NUMBER
to,O
protect,O
spreading,O
the,O
virus,O
to,O
the,O
public,O
[,O
67,NUMBER
],O
.,O
The,O
infected,O
person,O
should,O
take,O
rest,O
at,O
home,O
or,O
admit,O
to,O
the,O
hospital,O
for,O
complete,O
isolation,O
for,O
14,DURATION
days,DURATION
.,O
In,O
case,O
of,O
emergency,O
.,O
the,O
infected,O
person,O
should,O
wear,O
a,O
surgical,O
mask,O
to,O
protect,O
others,O
.,O
Potential,O
treatments,O
against,O
COVID,O
‐,O
19,NUMBER
As,O
we,O
know,O
.,O
no,O
effective,O
treatments,O
are,O
available,O
for,O
viral,O
diseases,CAUSE_OF_DEATH
[,O
57.58,NUMBER
],O
.,O
The,O
supportive,O
treatments,O
such,O
as,O
oxygen,O
therapy,O
.,O
con,O
‐,O
servation,O
fluid,O
management,O
.,O
and,O
the,O
use,O
of,O
broad,O
‐,O
spectrum,O
antibi,O
‐,O
otics,O
to,O
treat,O
secondary,O
bacterial,O
infection,CAUSE_OF_DEATH
are,O
still,O
practiced,O
as,O
important,O
management,O
are,O
used,O
to,O
reduce,O
lung,O
inflammation,O
[,O
59,NUMBER
],O
.,O
Some,O
of,O
the,O
drugs,CRIMINAL_CHARGE
such,O
as,O
oseltamivir,O
.,O
lopinavir,O
/,O
ritonavir,O
.,O
nucleoside,O
analogs,O
.,O
neuraminidase,O
inhibitors,O
.,O
remdesivir,O
.,O
umifen,O
‐,O
ovir,O
.,O
tenofovir,O
disoproxil,O
and,O
lamivudine,O
(,O
inhibitors,O
),O
.,O
chloro,O
‐,O
quine,O
.,O
and,O
Shufeng,PERSON
Jiedu,PERSON
or,O
Lianhua,O
Qingwen,O
capsules,O
(,O
traditional,O
medicines,O
of,O
China,COUNTRY
),O
are,O
advised,O
to,O
treat,O
COVID19,O
[,O
59.6870,NUMBER
],O
.,O
More,O
‐,O
over,O
.,O
some,O
inhibitors,O
such,O
as,O
3CLpro,O
(,O
3CLpro,O
‐,O
1,NUMBER
),O
and,O
a,O
novel,O
vinyl,O
sulfone,O
protease,O
and,O
angiotensin,O
‐,O
converting,O
enzyme,O
2,NUMBER
(,O
ACE2,O
),O
‐,O
based,O
peptide,O
showed,O
their,O
potentiality,O
against,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
[,O
71,NUMBER
],O
.,O
Usual,O
‐,O
ly,O
.,O
drugs,CRIMINAL_CHARGE
are,O
not,O
effective,O
against,O
viral,O
diseases,CAUSE_OF_DEATH
.,O
Recently,DATE
.,O
an,O
antiviral,O
drug,O
Favilavir,PERSON
has,O
approved,O
by,O
Chinas,ORGANIZATION
National,ORGANIZATION
Medical,ORGANIZATION
Products,O
Administration,O
on,O
16,DATE
February,DATE
2020,DATE
to,O
treat,O
COVID,O
‐,O
19,NUMBER
[,O
72,NUMBER
],O
.,O
This,O
drug,O
has,O
produced,O
by,O
Zhejiang,STATE_OR_PROVINCE
Hisun,LOCATION
Pharmaceutical,LOCATION
and,O
marketed,O
as,O
brand,O
name,O
Avigan,PERSON
[,O
73,NUMBER
],O
.,O
Current,DATE
challenges,O
of,O
COVID,O
‐,O
19,NUMBER
in,O
Bangladesh,COUNTRY
News,O
such,O
as,O
Coronavirus,O
Outbreak,O
:,O
Screen,O
‐,O
ing,O
still,O
lax,O
at,O
Dhaka,CITY
airport,O
in,O
the,O
Daily,SET
Star,O
on,O
10,DATE
March,DATE
2020,DATE
[,O
74,NUMBER
],O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
has,O
frustrated,O
the,O
governments,O
efforts,O
to,O
combat,O
the,O
deadly,O
COVID,O
‐,O
19,NUMBER
in,O
Bangladesh,COUNTRY
.,O
Few,O
initiatives,O
have,O
been,O
observed,O
at,O
the,O
Shah,LOCATION
Jalal,LOCATION
International,LOCATION
Airport,LOCATION
.,O
such,O
as,O
the,O
setting,O
of,O
some,O
thermal,O
scanners,O
to,O
check,O
the,O
realtime,O
body,O
temperature,O
of,O
the,O
passengers,O
and,O
filling,O
up,O
a,O
health,O
declaration,O
form,O
.,O
However,O
.,O
no,O
disinfection,O
activities,O
and,O
none,O
of,O
the,O
confirmation,O
tests,O
by,O
taking,O
samples,O
from,O
the,O
passengers,O
body,O
have,O
performed,O
.,O
According,O
to,O
the,O
WHO,ORGANIZATION
.,O
the,O
disease,CAUSE_OF_DEATH
could,O
remain,O
asymptomatic,O
for,O
up,O
to,O
14,NUMBER
days,DURATION
.,O
Therefore,O
.,O
thermal,O
scanner,TITLE
and,O
travel,O
history,O
are,O
not,O
enough,O
measures,O
to,O
detect,O
COVID,O
‐,O
19,NUMBER
among,O
the,O
passengers,O
.,O
Apart,O
from,O
passengers,O
scanning,O
.,O
no,O
initiatives,O
have,O
taken,O
to,O
disinfect,O
the,O
planes,O
and,O
luggage,O
of,O
the,O
passengers,O
.,O
There,O
is,O
a,O
misconcep,O
‐,O
tion,O
among,O
the,O
people,O
of,O
Bangladesh,COUNTRY
that,O
the,O
disease,CAUSE_OF_DEATH
would,O
not,O
sustain,O
in,O
the,O
country,O
due,O
to,O
the,O
onset,O
of,O
summer,DATE
when,O
the,O
tem,O
‐,O
perature,O
would,O
remain,O
above,O
30C,O
.,O
However,O
.,O
the,O
recent,O
study,O
re,O
‐,O
ported,O
that,O
temperature,O
does,O
not,O
change,O
the,O
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
[,O
46,NUMBER
],O
;,O
unlike,O
the,O
SARS,MISC
virus,O
.,O
there,O
is,O
no,O
evidence,O
that,O
the,O
outbreak,O
of,O
COVID,O
‐,O
19,NUMBER
would,O
be,O
reduced,O
at,O
higher,O
temperature,O
[,O
75,NUMBER
],O
.,O
Other,O
challenges,O
are,O
(,O
i,O
),O
lack,O
of,O
laboratory,O
facilities,O
for,O
the,O
early,O
detection,O
of,O
the,O
disease,CAUSE_OF_DEATH
.,O
(,O
ii,O
),O
scarcity,O
of,O
medical,O
sup,O
‐,O
plies,O
.,O
such,O
as,O
surgical,O
masks,O
and,O
goggles,O
.,O
(,O
iv,O
),O
lack,O
of,O
personal,O
protective,O
equipment,O
(,O
PPE,O
),O
for,O
healthcare,O
personnel,O
.,O
(,O
iv,O
),O
asymp,O
‐,O
tomatic,O
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
which,O
could,O
challenge,O
the,O
man,O
‐,O
agement,O
strategies,O
at,O
risk,O
[,O
41,NUMBER
],O
.,O
(,O
v,O
),O
lack,O
of,O
quarantine,O
facili,O
‐,O
ties,O
at,O
the,O
hospitals,O
.,O
(,O
v,O
),O
it,O
is,O
very,O
unfortunate,O
that,O
a,O
good,O
number,O
of,O
people,O
of,O
Bangladesh,COUNTRY
are,O
not,O
maintaining,O
good,O
hygiene,O
and,O
sanitation,O
practices,O
.,O
and,O
(,O
vi,O
),O
until,O
now,DATE
.,O
no,O
specific,O
drugs,CRIMINAL_CHARGE
or,O
vaccines,O
have,O
been,O
proven,O
effective,O
against,O
COVID,O
‐,O
19,NUMBER
.,O
Global,O
‐,O
ly,O
.,O
as,O
there,O
are,O
no,O
vaccines,O
discovered,O
against,O
novel,O
coronavirus,O
disease,CAUSE_OF_DEATH
COVID,O
‐,O
19,NUMBER
;,O
therefore,O
.,O
prevention,O
and,O
management,O
are,O
the,O
best,O
ways,O
to,O
tackle,O
this,O
deadly,O
disease,CAUSE_OF_DEATH
.,O
By,O
comparing,O
the,O
global,O
outbreak,O
.,O
confirmed,O
cases,O
are,O
only,O
0.003,PERCENT
%,PERCENT
in,O
Bangladesh,COUNTRY
[,O
8,NUMBER
],O
.,O
How,O
‐,O
ever,O
.,O
stern,O
actions,O
should,O
be,O
taken,O
immediately,O
so,O
that,O
further,O
penetration,O
of,O
any,O
case,O
is,O
not,O
possible,O
through,O
the,O
land,O
‐,O
.,O
sea,O
‐,O
.,O
and,O
airports,O
.,O
Nationally,O
.,O
public,O
awareness,O
is,O
the,O
crucial,O
factor,O
in,O
protecting,O
this,O
disease,CAUSE_OF_DEATH
.,O
The,O
health,O
officials,O
.,O
doctors,O
.,O
and,O
to,O
educate,O
them,O
about,O
the,O
protection,O
and,O
safety,O
measures,O
against,O
COVID,O
‐,O
19,NUMBER
.,O
Early,O
and,O
quick,O
detection,O
are,O
essential,O
measures,O
to,O
stop,O
the,O
transmission,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
The,O
diagnostic,O
facilities,O
of,O
Bangladesh,COUNTRY
should,O
be,O
improved,O
by,O
providing,O
the,O
detection,O
facili,O
‐,O
ties,O
at,O
all,O
the,O
divisional,O
.,O
district,O
.,O
and,O
upazilla,O
hospitals,O
.,O
Once,DATE
a,O
new,O
case,O
is,O
detected,O
.,O
he,O
should,O
be,O
isolated,O
immediately,O
.,O
Some,O
general,TITLE
recommendations,O
are,O
suggested,O
as,O
(,O
i,O
),O
as,O
per,O
the,O
WHOs,O
guidelines,O
[,O
23,NUMBER
],O
.,O
hand,O
hygiene,O
must,O
be,O
maintained,O
by,O
cleaning,O
hands,O
with,O
soap,O
and,O
water,O
for,O
at,DURATION
least,DURATION
20,DURATION
seconds,DURATION
or,O
using,O
alco,O
‐,O
hol,O
‐,O
based,O
hand,O
sanitizer,O
.,O
(,O
ii,O
),O
avoid,O
contact,O
hands,O
with,O
eyes,O
.,O
nose,O
.,O
and,O
mouth,O
.,O
(,O
iii,O
),O
the,O
use,O
of,O
disposable,O
tissues,O
or,O
clothing,O
when,O
coughs,O
and,O
sneezes,O
.,O
(,O
iv,O
),O
health,O
personnel,O
must,O
ensure,O
PPE,O
while,O
working,O
.,O
(,O
v,O
),O
avoid,O
interpersonal,O
contact,O
such,O
as,O
kissing,O
.,O
handshaking,O
.,O
and,O
so,O
on,O
.,O
(,O
vi,O
),O
avoid,O
mass,O
gathering,O
and,O
seek,O
medi,O
‐,O
cal,O
care,O
when,O
anyone,O
feels,O
fever,CAUSE_OF_DEATH
.,O
cough,O
.,O
and,O
difficulty,O
breath,O
‐,O
ing,O
.,O
(,O
ix,O
),O
once,DATE
a,O
person,O
is,O
detected,O
positive,O
with,O
COVID,O
‐,O
19,NUMBER
.,O
he,O
must,O
be,O
isolated,O
for,O
at,DURATION
least,DURATION
14,DURATION
days,DURATION
.,O
(,O
x,O
),O
operation,O
of,O
public,O
transportations,O
such,O
as,O
local,O
buses,O
.,O
launches,O
.,O
and,O
trains,O
should,O
be,O
limited,O
for,O
23,DURATION
weeks,DURATION
.,O
and,O
(,O
xi,O
),O
passengers,O
return,O
from,O
abroad,O
should,O
be,O
self,O
‐,O
quarantined,O
for,O
2,DURATION
weeks,DURATION
.,O
Specific,O
recommendations,O
to,O
the,O
government,O
are,O
as,O
(,O
i,O
),O
Apart,O
from,O
European,NATIONALITY
flights,O
.,O
passengers,O
from,O
other,O
infected,O
countries,O
such,O
as,O
China,COUNTRY
.,O
the,O
should,O
undergo,O
extensive,O
screening,O
and,O
.,O
if,O
possible,O
.,O
should,O
be,O
kept,O
in,O
force,O
isolation,O
for,O
2,DURATION
weeks,DURATION
.,O
Besides,O
.,O
the,O
planes,O
and,O
luggage,O
arriving,O
from,O
these,O
countries,O
should,O
be,O
disinfected,O
.,O
Compulsory,O
screening,O
of,O
passengers,O
must,O
be,O
maintained,O
at,O
all,O
the,O
entry,O
points,O
of,O
Bangladesh,COUNTRY
.,O
(,O
ii,O
),O
Collaborative,O
research,O
be,O
‐,O
tween,O
the,O
WHO,ORGANIZATION
and,O
government,O
or,O
nongovernment,O
organizations,O
should,O
be,O
carried,O
out,O
immediately,O
to,O
develop,O
a,O
vaccine,O
for,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
.,O
(,O
iii,O
),O
Providing,O
sufficient,O
funds,O
to,O
conduct,O
research,O
on,O
epidemiology,O
.,O
surveillance,O
.,O
and,O
management,O
of,O
COVID,O
‐,O
19,NUMBER
in,O
Bangladesh,COUNTRY
.,O
(,O
iv,O
),O
Frequently,O
circulate,O
the,O
news,O
of,O
public,O
awareness,O
and,O
precautions,O
about,O
COVID,O
‐,O
19,NUMBER
in,O
mass,O
Nothing,O
to,O
dis,O
‐,O
close,O
.,O
Conflict,O
of,O
interests,O
Mohammad,PERSON
Shah,PERSON
Alam,PERSON
was,O
involved,O
in,O
the,O
planning,O
and,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
Nazmul,PERSON
Hussain,PERSON
Nazir,PERSON
and,O
Md,STATE_OR_PROVINCE
.,O
Abdullahil,PERSON
Baki,PERSON
Bhuiyan,PERSON
Beaudette,PERSON
FR,O
.,O
Hudson,ORGANIZATION
CB,ORGANIZATION
.,O
Cultivation,O
of,O
the,O
virus,O
of,O
infectious,O
bronchitis,CAUSE_OF_DEATH
.,O
J,O
Am,O
Vet,O
Med,O
Assoc,O
1937,DATE
;,O
90:5160,NUMBER
.,O
Wang,PERSON
W,PERSON
.,O
Lin,PERSON
XD,O
.,O
Guo,PERSON
WP,O
.,O
Zhou,PERSON
RH,O
.,O
Wang,PERSON
MR,PERSON
.,O
Wang,O
CQ,O
et,O
al,O
.,O
Discovery,O
.,O
diversity,O
and,O
evolution,O
of,O
novel,O
coronaviruses,O
sampled,O
Gaunt,O
ER,O
.,O
Hardie,PERSON
A,O
.,O
Claas,ORGANIZATION
EC,ORGANIZATION
.,O
Sim,PERSON
‐,PERSON
monds,O
P,O
.,O
Templeton,ORGANIZATION
KE,ORGANIZATION
.,O
Epidemiology,O
and,O
clinical,O
presentations,O
of,O
the,O
four,NUMBER
human,O
coronaviruses,O
229E,O
.,O
HKU1,O
.,O
NL63,O
.,O
and,O
OC43,O
de,O
‐,O
tected,O
over,O
3,DURATION
years,DURATION
using,O
a,O
novel,O
multiplex,O
real,O
‐,O
time,O
PCR,O
method,O
.,O
J,O
Clin,O
Microbiol,O
2010,DATE
;,O
Kahn,PERSON
JS,O
.,O
McIntosh,PERSON
K.,PERSON
History,PERSON
and,O
recent,O
advances,O
in,O
coronavirus,O
Lin,PERSON
S,PERSON
.,O
Lee,PERSON
CK,PERSON
.,O
Lee,PERSON
SY,PERSON
.,O
Kao,ORGANIZATION
CL,ORGANIZATION
.,O
Lin,PERSON
CW,PERSON
.,O
Wang,ORGANIZATION
AB,ORGANIZATION
.,O
et,O
al,O
.,O
Surface,O
ultrastructure,O
of,O
SARS,O
coronavirus,O
re,O
‐,O
vealed,O
by,O
atomic,O
force,O
Centers,ORGANIZATION
for,ORGANIZATION
Disease,ORGANIZATION
Control,ORGANIZATION
and,ORGANIZATION
Prevention,ORGANIZATION
CDC,ORGANIZATION
.,O
Outbreak,O
of,O
severe,O
acute,O
respiratory,O
syndrome,O
‐‐,O
worldwide,O
.,O
MMWR,O
‐,O
Morbid,O
Mortal,O
W,O
2003,DATE
;,O
52,NUMBER
(,O
11,NUMBER
),O
:,O
226,NUMBER
.,O
World,O
Health,O
Organiza,O
‐,O
tion,O
(,O
WHO,O
),O
.,O
Novel,O
coronavirus,O
(,O
2019,DATE
‐,O
nCoV,O
),O
.,O
default,O
‐,O
source,O
/,O
coron,O
‐,O
aviruse,O
/,O
situation,O
‐,O
re,O
‐,O
ports,O
/,O
20200315,NUMBER
‐,O
sitrep,O
‐,O
55,NUMBER
‐,O
covid,O
‐,O
19.pdf,O
?,O
sfvrsn,O
=,O
33daa5cb_6,NUMBER
(,O
Accessed,O
16,DATE
March,DATE
Ashour,PERSON
HM,O
.,O
Elkhatib,ORGANIZATION
WF,ORGANIZATION
.,O
Rahman,PERSON
MM,O
.,O
Elshabrawy,PERSON
HA,PERSON
.,O
In,O
‐,O
sights,O
into,O
the,O
Recent,O
2019,DATE
Novel,O
Coronavirus,O
(,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
),O
in,O
Light,O
of,O
Past,DATE
Human,O
Coronavirus,O
Outbreaks,O
.,O
Pathogens,O
2020,DATE
;,O
9,NUMBER
(,O
3,NUMBER
),O
:,O
pii,O
:,O
Matoba,O
Y,O
.,O
Aoki,O
Y,O
.,O
Tanaka,PERSON
S,O
.,O
Yahagi,PERSON
K,PERSON
.,O
Shimotai,O
Y,O
.,O
Matsuzaki,PERSON
Y,O
.,O
et,O
al,O
.,O
An,O
outbreak,O
of,O
human,O
coronavirus,O
OC43,O
during,O
the,O
2014,DATE
2015,DATE
influenza,CAUSE_OF_DEATH
season,O
in,O
Yamagata,LOCATION
.,O
Japan,COUNTRY
.,O
Jpn,O
J,O
Infect,O
Dis,O
2015,DATE
;,O
Chen,O
X,O
.,O
Chughtai,ORGANIZATION
AA,ORGANIZATION
.,O
Dyda,O
A,O
.,O
MacIntyre,O
CR,O
.,O
Comparative,O
epidemiol,O
‐,O
ogy,O
of,O
Middle,LOCATION
East,LOCATION
respiratory,O
syndrome,O
coronavirus,O
(,O
MERSCoV,O
),O
in,O
Saudi,COUNTRY
Arabia,COUNTRY
and,O
South,COUNTRY
Korea,COUNTRY
.,O
Emerg,O
Microbes,O
Infec,O
2017,DATE
;,O
Ahmad,PERSON
T,PERSON
.,O
Rodriguez,PERSON
‐,O
Morales,O
AJ,O
.,O
Emergence,O
of,O
COVID,O
‐,O
19,NUMBER
(,O
formerly,O
Lai,O
CC,O
.,O
Shih,PERSON
TP,O
.,O
Ko,PERSON
WC,O
.,O
Tang,O
HJ,O
.,O
Hsueh,PERSON
PR,STATE_OR_PROVINCE
.,O
Severe,O
acute,O
respiratory,O
syn,O
‐,O
drome,O
coronavirus,O
2,NUMBER
(,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
),O
and,O
coronavirus,O
disease,CAUSE_OF_DEATH
‐,O
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
:,O
the,O
epidemic,O
and,O
the,O
challenges,O
.,O
Int,PERSON
J,PERSON
Lu,PERSON
R,PERSON
.,O
Zhao,PERSON
X,PERSON
.,O
Li,PERSON
J,PERSON
.,O
Niu,PERSON
P,O
.,O
Yang,PERSON
B,PERSON
.,O
Wu,PERSON
H,PERSON
.,O
et,O
al,O
.,O
Genomic,O
characterisation,O
and,O
epidemiology,O
of,O
2019,DATE
novel,O
coronavirus,O
:,O
implications,O
for,O
virus,O
origins,O
and,O
receptor,O
binding,O
.,O
Lancet,O
2020,DATE
;,O
395,NUMBER
(,O
10224,NUMBER
),O
:,O
565,NUMBER
Jiang,PERSON
S,O
.,O
Du,PERSON
L,PERSON
.,O
Shi,O
Z.,O
2020,DATE
.,O
An,O
emerging,O
coronavirus,O
causing,O
pneumonia,CAUSE_OF_DEATH
outbreak,O
in,O
Wuhan,CITY
.,O
China,COUNTRY
:,O
calling,O
for,O
developing,O
therapeutic,O
and,O
prophylactic,O
strategies,O
.,O
Emerg,O
Microbes,O
Infec,O
2020,DATE
;,O
Kim,PERSON
JY,PERSON
.,O
Choe,PERSON
PG,O
.,O
Oh,O
Y,O
.,O
Oh,O
KJ,O
.,O
Kim,PERSON
J,PERSON
.,O
Park,O
SJ,O
.,O
et,O
al,O
.,O
The,O
first,ORDINAL
case,O
of,O
2019,DATE
novel,O
coronavirus,O
pneumonia,CAUSE_OF_DEATH
imported,O
into,O
Korea,COUNTRY
from,O
Zhu,PERSON
N,PERSON
.,O
Zhang,PERSON
D,O
.,O
Wang,PERSON
W,PERSON
.,O
Li,PERSON
X,PERSON
.,O
Yang,PERSON
B,O
.,O
Song,O
J,O
.,O
et,O
al,O
.,O
A,O
novel,O
coronavirus,O
from,O
patients,O
with,O
pneumonia,CAUSE_OF_DEATH
in,O
China,COUNTRY
.,O
2019,DATE
.,O
New,O
Engl,O
J,O
Med,O
World,O
Health,ORGANIZATION
Organization,ORGANIZATION
(,O
WHO,O
),O
.,O
Novel,O
Coronavirus,O
Chu,O
YK,O
.,O
Ali,PERSON
GD,O
.,O
Jia,PERSON
F,O
.,O
Li,PERSON
Q,O
.,O
Kelvin,PERSON
D,PERSON
.,O
Couch,O
RC,O
.,O
et,O
al,O
.,O
The,O
SARSCoV,O
ferret,O
model,TITLE
in,O
an,O
infectionchallenge,O
study,O
.,O
Virology,O
2008,DATE
;,O
Mahase,PERSON
E.,PERSON
Coron,PERSON
‐,O
avirus,O
:,O
covid,O
‐,O
19,NUMBER
has,O
killed,O
more,O
people,O
than,O
SARS,O
and,O
MERS,O
com,O
‐,O
bined,O
.,O
despite,O
lower,O
case,O
fatality,O
rate,O
.,O
BMJ,LOCATION
2020,DATE
;,O
World,O
Health,O
Organization,O
.,O
Water,O
.,O
sanitation,O
.,O
hygiene,O
and,O
waste,O
management,O
for,O
COVID,O
‐,O
19,NUMBER
:,O
technical,O
brief,O
.,O
03.03,NUMBER
/,O
2020,DATE
(,O
No,O
.,O
The,O
Prothom,O
alo,O
.,O
DSE,ORGANIZATION
.,O
CSE,ORGANIZATION
post,O
massive,O
plunge,O
.,O
Available,O
via,O
The,O
India,ORGANIZATION
Today,ORGANIZATION
.,O
PM,O
Modis,PERSON
Dhaka,CITY
trip,O
cancelled,O
after,O
3,NUMBER
coronavirus,O
The,O
Independent,RELIGION
.,O
Panic,O
buying,O
triggers,O
mask,O
.,O
sanitiser,O
crises,O
.,O
Casanova,ORGANIZATION
LM,ORGANIZATION
.,O
Jeon,PERSON
S,PERSON
.,O
Ru,O
‐,O
tala,O
WA,STATE_OR_PROVINCE
.,O
Weber,PERSON
DJ,PERSON
.,O
Sobsey,PERSON
MD,O
.,O
Effects,O
of,O
air,O
temperature,O
and,O
rel,O
‐,O
ative,O
humidity,O
on,O
coronavirus,O
survival,O
on,O
Booth,O
TF,O
.,O
Kournikakis,PERSON
B,O
.,O
Bastien,PERSON
N,O
.,O
Ho,PERSON
J,PERSON
.,O
Kobasa,PERSON
D,O
.,O
Stadnyk,O
L,O
.,O
et,O
al,O
.,O
Detection,O
of,O
air,O
‐,O
borne,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
coronavirus,O
and,O
environmental,O
contamination,O
in,O
SARS,O
Alghamdi,O
IG,O
.,O
Hussain,PERSON
II,PERSON
.,O
Al,O
‐,O
malki,O
SS,O
.,O
Alghamdi,PERSON
MS,STATE_OR_PROVINCE
.,O
Alghamdi,PERSON
MM,O
.,O
El,O
‐,O
Sheemy,O
MA,STATE_OR_PROVINCE
.,O
2014,DATE
.,O
The,O
pat,O
‐,O
tern,O
of,O
Middle,LOCATION
East,LOCATION
respiratory,O
syndrome,O
coronavirus,O
in,O
Saudi,NATIONALITY
Arabia,O
:,O
a,O
descriptive,O
epidemiological,O
analysis,O
of,O
data,O
from,O
the,O
Saudi,ORGANIZATION
Ministry,ORGANIZATION
of,ORGANIZATION
Health,ORGANIZATION
.,O
Int,PERSON
J,PERSON
Gen,PERSON
Med,PERSON
Luo,PERSON
W,PERSON
.,O
Majumder,PERSON
MS,STATE_OR_PROVINCE
.,O
Liu,PERSON
D,O
.,O
Poirier,PERSON
C,O
.,O
Mandl,ORGANIZATION
KD,ORGANIZATION
.,O
Lipsitch,O
M,O
.,O
et,O
al,O
.,O
The,O
role,O
of,O
absolute,O
humidity,O
on,O
transmission,O
Wang,PERSON
M,O
.,O
Jiang,PERSON
A,O
.,O
Gong,O
L,O
.,O
Luo,PERSON
L,PERSON
.,O
Guo,PERSON
W,PERSON
.,O
Li,PERSON
C,PERSON
.,O
et,O
al,O
.,O
Temperature,O
significant,O
change,O
COVID,O
‐,O
19,NUMBER
Transmission,O
in,O
429,NUMBER
cities,O
.,O
medRxiv,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
Huang,PERSON
C,PERSON
.,O
Wang,O
Y,O
.,O
Li,PERSON
X,PERSON
.,O
Ren,PERSON
L,PERSON
.,O
Zhao,PERSON
J,PERSON
.,O
Hu,O
Y,O
.,O
et,O
al,O
.,O
Clinical,O
fea,O
‐,O
tures,O
of,O
patients,O
infected,O
with,O
2019,DATE
novel,O
coronavirus,O
in,O
Wuhan,CITY
.,O
Chan,RELIGION
JF,O
.,O
Yuan,PERSON
S,PERSON
.,O
Kok,PERSON
KH,O
.,O
To,ORGANIZATION
KK,ORGANIZATION
.,O
Chu,PERSON
H,PERSON
.,O
Yang,PERSON
J,PERSON
.,O
et,O
al,O
.,O
A,O
familial,O
cluster,O
of,O
pneumonia,CAUSE_OF_DEATH
associated,O
with,O
the,O
2019,DATE
novel,O
coronavirus,O
Coronavirus,O
disease,CAUSE_OF_DEATH
(,O
COVID,O
‐,O
19,NUMBER
),O
advice,O
for,O
the,O
public,O
.,O
World,O
Health,ORGANIZATION
Organization,ORGANIZATION
.,O
Geneva,CITY
.,O
Switzerland,COUNTRY
.,O
2020,DATE
.,O
Available,O
via,O
Rothe,PERSON
C,O
.,O
Schunk,PERSON
M,O
.,O
Sothmann,O
P,O
.,O
Bretzel,PERSON
G,PERSON
.,O
Froeschl,PERSON
G,PERSON
.,O
Wallrauch,PERSON
C,O
.,O
et,O
al,O
.,O
Transmission,O
of,O
2019nCoV,O
Infection,CAUSE_OF_DEATH
from,O
an,O
asymptomatic,O
contact,O
in,O
Germany,COUNTRY
.,O
New,O
Engl,O
J,O
Med,O
2020,DATE
;,O
382,NUMBER
(,O
10,NUMBER
),O
:,O
9701,DATE
;,O
Huda,PERSON
ASN,O
.,O
Mekhilef,PERSON
S,PERSON
.,O
Ahsan,PERSON
A.,O
2014,DATE
.,O
Biomass,O
energy,O
in,O
Bangladesh,COUNTRY
:,O
current,DATE
status,O
and,O
prospects,O
.,O
Renew,O
Sust,ORGANIZATION
Energ,ORGANIZATION
Rev,ORGANIZATION
Eccles,ORGANIZATION
R,ORGANIZATION
.,O
An,O
explana,O
‐,O
tion,O
for,O
the,O
seasonality,O
of,O
acute,O
upper,O
respiratory,O
tract,O
viral,O
infections,CAUSE_OF_DEATH
.,O
Acta,O
Otolaryngol,O
2002,DATE
;,O
122:18391,NUMBER
;,O
Kudo,PERSON
E,O
.,O
Song,O
E,O
.,O
Yockey,PERSON
LJ,PERSON
.,O
Rakib,PERSON
T,PERSON
.,O
Wong,PERSON
PW,O
.,O
Homer,PERSON
RJ,PERSON
.,O
et,O
al,O
.,O
Low,O
ambient,O
humid,O
‐,O
ity,O
impairs,O
barrier,O
function,O
and,O
innate,O
resistance,O
against,O
in,O
‐,O
fluenza,O
infection,CAUSE_OF_DEATH
.,O
Proc,ORGANIZATION
Natl,ORGANIZATION
Acad,ORGANIZATION
Sci,ORGANIZATION
USA,ORGANIZATION
2019,DATE
;,O
Peiris,PERSON
JS,O
.,O
Guan,PERSON
Y,O
.,O
Yuen,LOCATION
KY,LOCATION
.,O
Severe,O
acute,O
respiratory,O
syndrome,O
.,O
Nat,PERSON
Verma,PERSON
GP,O
.,O
Fun,O
‐,O
damentals,O
of,O
histology,O
.,O
New,RELIGION
Age,RELIGION
International,O
Pvt,TITLE
Zhao,PERSON
J,PERSON
.,O
Zhao,PERSON
J,PERSON
.,O
Van,PERSON
Rooijen,PERSON
N,PERSON
.,O
Perlman,PERSON
S.,O
Evasion,O
by,O
stealth,O
.,O
Inefficient,O
immune,O
activation,O
underlies,O
poor,O
T,O
cell,O
response,O
and,O
severe,O
disease,CAUSE_OF_DEATH
in,O
SARS,O
‐,O
CoV,O
infected,O
mice,O
.,O
PloS,O
Pathog,O
2009,DATE
;,O
Velavan,O
TP,O
.,O
Meyer,PERSON
CG,O
.,O
The,O
COVID19,O
epidemic,O
.,O
Trop,O
Med,O
Int,O
Zu,O
ZY,O
.,O
Jiang,PERSON
MD,STATE_OR_PROVINCE
.,O
Xu,O
PP,O
.,O
Chen,PERSON
W,O
.,O
Ni,O
QQ,O
.,O
Lu,ORGANIZATION
GM,ORGANIZATION
.,O
et,O
al,O
.,O
Coronavirus,O
Disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
:,O
a,O
perspective,O
from,O
China,COUNTRY
.,O
Radiology,O
Ai,O
T,O
.,O
Yang,PERSON
Z,PERSON
.,O
Hou,PERSON
H,PERSON
.,O
Zhan,PERSON
C,PERSON
.,O
Chen,O
C,O
.,O
Lv,PERSON
W,PERSON
.,O
et,O
al,O
.,O
Correlation,O
of,O
chest,O
CT,STATE_OR_PROVINCE
and,O
RT,O
‐,O
PCR,O
testing,O
in,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
in,O
Fang,O
Y,O
.,O
Zhang,PERSON
H,PERSON
.,O
Xie,PERSON
J,PERSON
.,O
Lin,PERSON
M,O
.,O
Ying,PERSON
L,PERSON
.,O
Pang,PERSON
P,O
.,O
et,O
al,O
.,O
Sensitivity,O
of,O
chest,O
CT,STATE_OR_PROVINCE
for,O
COVID,O
‐,O
19,NUMBER
:,O
comparison,O
to,O
RT,O
‐,O
PCR,O
.,O
Radiology,O
2020,DATE
;,O
200432,NUMBER
;,O
Xie,PERSON
X,PERSON
.,O
Zhong,PERSON
Z,PERSON
.,O
Zhao,PERSON
W,PERSON
.,O
Zheng,PERSON
C,PERSON
.,O
Wang,PERSON
F,PERSON
.,O
Liu,PERSON
J.,PERSON
Chest,PERSON
CT,STATE_OR_PROVINCE
for,O
typical,O
2019,DATE
‐,O
nCoV,O
pneumonia,CAUSE_OF_DEATH
:,O
relationship,O
to,O
negative,O
RT,O
‐,O
PCR,O
To,O
KKW,O
.,O
Tsang,PERSON
OTY,PERSON
.,O
Yip,PERSON
CCY,O
.,O
Chan,ORGANIZATION
KH,ORGANIZATION
.,O
Wu,PERSON
TC,PERSON
.,O
Chan,ORGANIZATION
JMC,ORGANIZATION
.,O
et,O
al,O
.,O
Consistent,O
detection,O
of,O
2019,DATE
novel,O
coronavirus,O
in,O
saliva,O
.,O
Clin,PERSON
Guarner,PERSON
J.,PERSON
Three,NUMBER
emerging,O
coronaviruses,O
in,O
two,DURATION
decades,DURATION
the,O
story,O
of,O
SARS,O
.,O
MERS,O
.,O
and,O
Now,DATE
COVID,O
‐,O
19,NUMBER
.,O
Am,O
J,PERSON
Clin,PERSON
Pathol,PERSON
2020,DATE
;,O
Xiaowei,PERSON
L,PERSON
.,O
Manman,PERSON
G,O
.,O
Yizhao,PERSON
P,O
.,O
Liesu,PERSON
M,O
.,O
Shemin,PERSON
L.,PERSON
Molecular,PERSON
immune,O
pathogenesis,O
and,O
diagnosis,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
J,O
Pharmaceut,O
de,O
Wit,O
E,O
.,O
van,O
Doremalen,O
N,O
.,O
Falzarano,PERSON
D,O
.,O
Munster,O
VJ,O
.,O
SARS,O
and,O
MERS,O
:,O
recent,O
insights,O
into,O
emerging,O
coronaviruses,O
.,O
Nat,PERSON
Zumla,PERSON
A,O
.,O
Chan,PERSON
JF,PERSON
.,O
Azhar,PERSON
EI,PERSON
.,O
Hui,O
DS,O
.,O
Yuen,LOCATION
KY,LOCATION
.,O
Coronaviruses,MISC
‐,O
drug,O
The,O
SARS,O
.,O
MERS,O
and,O
novel,O
coron,O
‐,O
avirus,O
(,O
COVID,O
‐,O
19,NUMBER
),O
epidemics,O
.,O
the,O
newest,O
and,O
biggest,O
global,O
health,O
threats,O
:,O
what,O
lessons,O
have,O
Yeo,PERSON
C,PERSON
.,O
Kaushal,PERSON
S,PERSON
.,O
Yeo,PERSON
D.,PERSON
Enteric,PERSON
in,O
‐,O
volvement,O
of,O
coronaviruses,O
:,O
is,O
faecaloral,O
transmission,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
possible,O
?,O
Zaki,PERSON
AM,O
.,O
van,O
Boheemen,PERSON
S,PERSON
.,O
Bestebroer,PERSON
TM,PERSON
.,O
Oster,PERSON
‐,O
haus,O
AD,O
.,O
Fouchier,O
RA,O
.,O
Isolation,O
of,O
a,O
novel,O
coronavirus,O
from,O
a,O
man,O
with,O
pneumonia,CAUSE_OF_DEATH
in,O
n,O
e,O
w,O
s,O
‐,O
re,O
l,O
e,O
a,O
s,O
e,O
s,O
/,O
n,O
i,O
h,O
‐,O
c,O
l,O
i,O
n,O
i,O
c,O
a,O
l,O
‐,O
t,O
r,O
i,O
a,O
l,O
‐,O
i,O
nve,O
s,O
t,O
i,NUMBER
g,O
a,O
t,O
i,O
o,O
n,O
a,O
l,O
‐,O
va,O
c,O
cine,O
‐,O
covid,O
‐,O
19,NUMBER
‐,O
begins,O
(,O
Accessed,O
16,DATE
March,DATE
2020,DATE
),O
.,O
Riou,PERSON
J,PERSON
.,O
Althaus,PERSON
CL,O
.,O
Pattern,O
of,O
early,O
human,O
‐,O
to,O
‐,O
human,O
transmission,O
of,O
Wuhan,CITY
2019,DATE
novel,O
coronavirus,O
(,O
2019nCoV,O
),O
.,O
December,DATE
2019,DATE
European,NATIONALITY
Centre,O
for,O
Disease,CAUSE_OF_DEATH
Prevention,O
and,O
Control,ORGANIZATION
(,O
ECDC,ORGANIZATION
),O
Technical,O
report,O
.,O
Infection,CAUSE_OF_DEATH
preven,O
‐,O
tion,O
and,O
control,O
for,O
the,O
care,O
of,O
patients,O
with,O
2019,DATE
‐,O
nCoV,O
in,O
healthcare,O
settings,O
.,O
Available,O
via,O
nove,O
‐,O
coronavirus,O
‐,O
infection,CAUSE_OF_DEATH
‐,O
prevention,O
‐,O
controlpatients,O
‐,O
healthcare,O
‐,O
settings.pdf,O
(,O
Accessed,O
12,NUMBER
February,DATE
2020,DATE
),O
.,O
Li,O
Q,O
.,O
Guan,PERSON
X,PERSON
.,O
Wu,PERSON
P,O
.,O
Wang,O
X,O
.,O
Zhou,PERSON
L,PERSON
.,O
Tong,O
Y,O
.,O
et,O
al,O
.,O
Early,O
transmission,O
dynamics,O
in,O
Wuhan,CITY
.,O
China,COUNTRY
.,O
of,O
Novel,O
Coron,O
‐,O
avirus,O
‐,O
Infected,O
Amodio,O
E,O
.,O
Vitale,PERSON
F,O
.,O
Cimino,PERSON
L,O
.,O
Casuccio,O
A,O
.,O
Tramuto,PERSON
F.,O
Outbreak,O
of,O
Novel,O
Coronavirus,O
(,O
SARS,O
‐,O
Cov,O
‐,O
2,NUMBER
),O
:,O
First,ORDINAL
evidences,O
from,O
international,O
scientific,O
literature,O
and,O
pending,O
questions,O
.,O
Healthcare,ORGANIZATION
Lu,ORGANIZATION
H.,ORGANIZATION
Drug,ORGANIZATION
treatment,O
options,O
for,O
the,O
2019,DATE
‐,O
new,O
coron,O
‐,O
avirus,O
Wang,O
M,O
.,O
Cao,PERSON
R,PERSON
.,O
Zhang,PERSON
L,PERSON
.,O
Yang,PERSON
X,PERSON
.,O
Liu,PERSON
J,PERSON
.,O
Xu,O
M,O
.,O
et,O
al,O
.,O
Remde,O
‐,O
sivir,O
and,O
Wang,PERSON
L,PERSON
.,O
Shi,PERSON
W,PERSON
.,O
Joyce,PERSON
MG,PERSON
.,O
Modjarrad,PERSON
K,PERSON
.,O
Zhang,PERSON
Y,PERSON
.,O
Leung,PERSON
K,PERSON
.,O
et,O
al,O
.,O
Evaluation,O
of,O
candidate,TITLE
vaccine,O
approaches,O
for,O
MERS,O
‐,O
CoV,O
.,O
Morse,ORGANIZATION
JS,ORGANIZATION
.,O
Lalonde,PERSON
T,O
.,O
Xu,PERSON
S,PERSON
.,O
Liu,PERSON
WR,O
.,O
Learning,O
from,O
the,DATE
past,DATE
:,O
possi,O
‐,O
ble,O
urgent,O
prevention,O
and,O
treatment,O
options,O
for,O
severe,O
acute,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
respiratory,CAUSE_OF_DEATH
infections,CAUSE_OF_DEATH
caused,O
by,O
2019nCoV,O
.,O
Chembiochem,O
2020,DATE
;,O
Wang,PERSON
M,O
.,O
Jiang,PERSON
A,O
.,O
Gong,O
L,O
.,O
Luo,PERSON
L,PERSON
.,O
Guo,PERSON
W,PERSON
.,O
Li,PERSON
C,PERSON
.,O
et,O
al,O
.,O
Temperature,O
sig,O
‐,O
nificant,O
change,O
COVID,O
‐,O
19,NUMBER
Transmission,O
in,O
429,NUMBER
cities,O
.,O
medRxiv,O
Alam,PERSON
et,O
al.,O
/,O
J.,O
Adv.,O
Vet,O
.,O
Anim,O
.,O
Res.,O
.,O
7,NUMBER
(,O
2,NUMBER
),O
:,O
198208,NUMBER
.,O
June,DATE
2020,DATE
